These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 2416628)
21. Prognostic values of preoperative and postoperative CEA and CA19.9 levels in pancreatic cancer. Yasue M; Sakamoto J; Teramukai S; Morimoto T; Yasui K; Kuno N; Kurimoto K; Ohashi Y Pancreas; 1994 Nov; 9(6):735-40. PubMed ID: 7846017 [TBL] [Abstract][Full Text] [Related]
22. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice. Ng WW; Tong KJ; Tam TN; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181 [TBL] [Abstract][Full Text] [Related]
23. CA 19.9, CA 242 and CEA in the diagnosis and follow-up of pancreatic cancer. Banfi G; Bravi S; Ardemagni A; Zerbi A Int J Biol Markers; 1996; 11(2):77-81. PubMed ID: 8776607 [TBL] [Abstract][Full Text] [Related]
24. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9. Buccheri GF; Ferrigno D; Sartoris AM; Violante B; Vola F; Curcio A Cancer; 1987 Jul; 60(1):42-50. PubMed ID: 3472637 [TBL] [Abstract][Full Text] [Related]
25. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases. Satake K; Kanazawa G; Kho I; Chung Y; Umeyama K Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125 [TBL] [Abstract][Full Text] [Related]
27. The diagnostic value of the foetoacinar pancreatic (FAP) protein in cancer of the pancreas; a comparative study with CA19/9. Fujii Y; Albers GH; Carre-Llopis A; Escribano MJ Br J Cancer; 1987 Oct; 56(4):495-500. PubMed ID: 3479995 [TBL] [Abstract][Full Text] [Related]
28. A clinical evaluation of monoclonal (CA19-9, CA50, CA12-5) and polyclonal (CEA, TPA) antibody-defined antigens for the diagnosis of pancreatic cancer. Benini L; Cavallini G; Zordan D; Rizzotti P; Rigo L; Brocco G; Perobelli L; Zanchetta M; Pederzoli P; Scuro LA Pancreas; 1988; 3(1):61-6. PubMed ID: 3163149 [TBL] [Abstract][Full Text] [Related]
29. Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies. Yoshikawa T; Nishida K; Tanigawa M; Fukumoto K; Kondo M Digestion; 1985; 31(2-3):67-76. PubMed ID: 2581838 [TBL] [Abstract][Full Text] [Related]
30. Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas. Tatsuta M; Iishi H; Ichii M; Noguchi S; Yamamoto R; Yamamura H; Okuda S Cancer; 1986 May; 57(9):1836-9. PubMed ID: 2420441 [TBL] [Abstract][Full Text] [Related]
31. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy. Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876 [TBL] [Abstract][Full Text] [Related]
32. Carcinoembryonic antigen and carbohydrate antigen 19-9 levels of peripheral and draining venous blood in colorectal cancer patients. Correlation with histopathologic and immunohistochemical variables. Tabuchi Y; Deguchi H; Saitoh Y Cancer; 1988 Oct; 62(8):1605-13. PubMed ID: 3167774 [TBL] [Abstract][Full Text] [Related]
33. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer. Yin LK; Sun XQ; Mou DZ Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051 [TBL] [Abstract][Full Text] [Related]
34. CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis. Del Favero G; Fabris C; Plebani M; Panucci A; Piccoli A; Perobelli L; Pedrazzoli S; Baccaglini U; Burlina A; Naccarato R Cancer; 1986 Apr; 57(8):1576-9. PubMed ID: 3456255 [TBL] [Abstract][Full Text] [Related]
35. Serum concentration and immunohistochemical localization of SPan-1 antigen in pancreatic cancer. A comparison with CA19-9 antigen. Takeda S; Nakao A; Ichihara T; Suzuki Y; Nonami T; Harada A; Koshikawa T; Takagi H Hepatogastroenterology; 1991 Apr; 38(2):143-8. PubMed ID: 1855772 [TBL] [Abstract][Full Text] [Related]
36. Novel serum tumor marker, RCAS1, in pancreatic diseases. Yamaguchi K; Enjoji M; Nakashima M; Nakamuta M; Watanabe T; Tanaka M World J Gastroenterol; 2005 Sep; 11(33):5199-202. PubMed ID: 16127752 [TBL] [Abstract][Full Text] [Related]
37. [CA 12-5 in cancer of the digestive tract. A comparison with CA 19-9 and CEA in cancer of the pancreas and colon]. Klapdor R; Klapdor U; Bahlo M; Dallek M; Kremer B; van Ackeren H; Schreiber HW; Greten H Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1949-54. PubMed ID: 6595110 [TBL] [Abstract][Full Text] [Related]
38. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions. Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676 [TBL] [Abstract][Full Text] [Related]
39. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in patients with colorectal cancer]. Deguchi H; Tabuchi Y; Saitoh Y Nihon Geka Gakkai Zasshi; 1988 May; 89(5):671-83. PubMed ID: 3166103 [TBL] [Abstract][Full Text] [Related]
40. [Role of carcinoembryonic antigen, carbohydrate antigen 19-9 and cytology of bile in diagnosis of biliary and pancreatic cancer]. Matsuda M; Shimizu Y; Chikamatsu E; Takayanagi K; Ishigure H; Murakami S; Odani K Nihon Geka Gakkai Zasshi; 1991 Jun; 92(6):716-21. PubMed ID: 1886576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]